By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
It enters the intestines via the rectum or esophagus and projects a color image of the intestinal tract onto a monitor.
The same opportunity to examine the gastrointestinal tract is provided by interventional endoscopy; However, it also enables the endoscopist to carry out internal surgical procedures.
Interventional endoscopy is an area of medicine that uses instruments inserted through the body’s natural openings, such as the mouth and anus, to diagnose and treat diseases.
It is used to treat a wide variety of conditions, such as gastrointestinal (GI) disorders, respiratory disorders, blood vessel disorders, and cancer. In recent years, the market for interventional endoscopy has grown rapidly due to the increasing demand for minimally invasive treatments.
The Global Interventional Endoscope market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The ENSIST project (Endoscopic Simulation for Surgical Training), supported by the Region Grand Est, for the development of simulation modules dedicated to learning new surgical techniques using endoscopy approach, has been launched by the Strasbourg-based company InSimo, which specialises in the development of simulation software for medical and surgical training.
Patients’ safety and comfort during and after surgery are guaranteed by the new surgical techniques, which favour less and less invasive approaches.
The majority of them concentrate on the diagnostic side of the endoscopic examination, but they don’t let people learn about new interventional endoscopy techniques, which is where InSimo wants to be.
In point of fact, the patient-specific simulation that was developed at InSimo makes it possible to implement a wide variety of patient cases and pathologies.
As part of the ENSIST project, InSimo proposes to develop simulation modules for ESD and ESG training.
This makes it very interesting for the effective practice of complex interventional endoscopic procedures.
InSimo will use patient data from medical imaging to create virtual clinical cases by providing interactive biomechanical simulations of the organs involved in these interventions.
In order to replicate the procedures as a whole, the surgical interactions for all navigation and interventional gestures will be simulated.
To replicate the haptic and gestural sensations of a real surgery, the simulation can be used in conjunction with a hardware console. Exercises with specific educational goals will incorporate the learning of these surgical gestures.
One of the most prominent partnerships in the interventional endoscope market is between Olympus Corporation and Boston Scientific. The two companies announced a strategic collaboration to develop and commercialize advanced endoscopic technologies.
The agreement will focus on creating next-generation endoscopic tools that combine Olympus’s expertise in endoscopy with Boston Scientific’s expertise in medical device engineering.
Another key partnership was announced between Stryker Corporation and EndoChoice, a specialist in advanced endoscopic technologies. The agreement will focus on developing new technologies that will improve the diagnosis and treatment of gastrointestinal diseases.
The collaboration provides Stryker with access to EndoChoice’s products and expertise, while EndoChoice gains access to Stryker’s sales and distribution channels.
Yet another partnership was announced between Johnson & Johnson and Pentax Medical. The companies have agreed to collaborate in the development and commercialization of new endoscopy solutions.
Johnson & Johnson will provide its expertise in medical device engineering and Pentax Medical will provide its expertise in endoscopy.
Another significant acquisition in the interventional endoscopy market was announced, when Hoya Corporation acquired EndoChoice. The acquisition will help Hoya expand its product portfolio and gain access to EndoChoice’s advanced endoscopy technologies.
These partnerships and acquisitions are a testament to the growing demand for interventional endoscopy solutions. They are also indicative of the increasing number of companies investing in the market.
As the demand for minimally invasive treatments continues to increase, these partnerships and acquisitions are likely to continue in the future.
The i10 line of endoscopes from Pentax Medical is made to offer high-definition (HD+) visualisation during endoscopic procedures, which can aid doctors in more precisely identifying lesions or anomalies.
Advanced navigation features, like responsive insertion and enhanced manoeuvrability, are also available with the i10 series, which can aid doctors in carrying out treatments more successfully and quickly.
Doctors can more clearly see the inside of the body because to the HD+ technology utilised in the i10 series, which produces sharper, more detailed images.
When performing procedures that need for the exact localization and targeting of lesions or other anomalies, this might be extremely helpful. The i10 series also has an ergonomic design that might lessen operator fatigue during prolonged treatments, boosting the comfort of both patients and doctors.
The i10 series, which offers enhanced imaging and navigation capabilities that can help to improve patient outcomes and increase the effectiveness of endoscopic treatments, marks an important achievement in the field of interventional endoscopy overall.
